A carregar...
Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High Risk Patients with Heart Failure
BACKGROUND: Heart failure (HF) guidelines recommend routine monitoring of serum potassium and renal function in patients treated with a mineralocorticoid receptor antagonist (MRA). How these recommendations are implemented in high risk patients or according to setting of drug initiation is poorly ch...
Na minha lista:
| Publicado no: | Circ Cardiovasc Qual Outcomes |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228387/ https://ncbi.nlm.nih.gov/pubmed/28073850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.116.002946 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|